silver norfloxacin has been researched along with nalidixic acid in 1 studies
*Nalidixic Acid: A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. [MeSH]
*Nalidixic Acid: A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. [MeSH]
| Studies (silver norfloxacin) | Trials (silver norfloxacin) | Recent Studies (post-2010) (silver norfloxacin) | Studies (nalidixic acid) | Trials (nalidixic acid) | Recent Studies (post-2010) (nalidixic acid) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 3,246 | 87 | 340 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darrell, RW; Fox, CL; Modak, SM | 1 |
1 other study(ies) available for silver norfloxacin and nalidixic acid
| Article | Year |
|---|---|
Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Corneal Ulcer; Drug Evaluation, Preclinical; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Pseudomonas Infections; Rabbits | 1984 |